News for 'US Food and Drug Administration'

Ranbaxy hires BCG, Mercer for internal strategic project

Ranbaxy hires BCG, Mercer for internal strategic project

Rediff.com1 Jun 2013

Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.

Meet the man behind the Sun Pharma-Ranbaxy deal

Meet the man behind the Sun Pharma-Ranbaxy deal

Rediff.com8 Apr 2014

Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.

Khurshid raises concern over Devyani issue with Kerry

Khurshid raises concern over Devyani issue with Kerry

Rediff.com23 Jan 2014

Upset over the Devyani Khobragade episode, India on Wednesday raised with the United States its concerns over "trafficking" visas issued to family members of Sangita Richard, the absconding maid of the Indian diplomat whose arrest had triggered a row between the two countries.

'Khalistanis are a microscopic minority in Punjab'

'Khalistanis are a microscopic minority in Punjab'

Rediff.com4 Apr 2023

'The Khalistanis get bulk of the money from abroad.' 'Where did Amritpal's Mercedes come from, which costs well over Rs 60 lakhs?' 'Where does his fleet of vehicles come from?' 'Local Punjabis can certainly not contribute this kind of money.'

Oil from cannabis seed is the new elixir

Oil from cannabis seed is the new elixir

Rediff.com25 Jan 2020

CBD oil, found in marijuana, is gaining popularity for its pain-relieving properties. It's now legally available in India

US allows 'game-changer' saliva-based Covid test

US allows 'game-changer' saliva-based Covid test

Rediff.com16 Aug 2020

The new test it will enable rapid testing amongst more people easily.

2017 begins with a bang for outbound M&A deals

2017 begins with a bang for outbound M&A deals

Rediff.com31 Jan 2017

Indian companies have made acquisitions of $1 billion so far in January

ICMR to conduct nationwide sero surveys on Covid spread

ICMR to conduct nationwide sero surveys on Covid spread

Rediff.com12 Jun 2021

The Indian Council of Medical Research will start national-level sero surveys to assess the spread of Covid-19 and all states/Union territories should also be encouraged to conduct them so that information from all geographies can be collected, the Union health ministry said on Friday.

Daiichi drags Malvinder to Singapore court

Daiichi drags Malvinder to Singapore court

Rediff.com12 Nov 2013

In 2008, Daiichi Sankyo had bought the entire 34.82 per cent stake in Ranbaxy from its promoters, Malvinder Mohan Singh and family, for $4.2 billion. Currently, Singh is executive chairman of Fortis Healthcare.

Booster dose of anti-Covid vax not needed at this stage: Experts

Booster dose of anti-Covid vax not needed at this stage: Experts

Rediff.com18 Sep 2021

As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.

'Shift FSSAI from health to consumer affairs ministry'

'Shift FSSAI from health to consumer affairs ministry'

Rediff.com8 Jul 2015

The matter is now expected to be raised with the PMO.

Earning woes drag markets lower; TCS, HUL lead fall

Earning woes drag markets lower; TCS, HUL lead fall

Rediff.com14 Oct 2015

Earning woes drag markets lower; TCS, HUL lead fall.

Markets end lower on Bihar verdict; Nifty holds 7,900

Markets end lower on Bihar verdict; Nifty holds 7,900

Rediff.com9 Nov 2015

TCS, Infosys and Wipro were down 0.4-2% each. Capital goods majors also ended lower with L&T and BHEL down 1.4-3.9% each.

2 Indian Americans among richest entrepreneurs under 40

2 Indian Americans among richest entrepreneurs under 40

Rediff.com19 Nov 2015

Zuckerberg leads the pack with a net worth of $47.1 billion.

Sensex ends over 200 points lower on weak European cues

Sensex ends over 200 points lower on weak European cues

Rediff.com28 Sep 2015

Investors will maintain a cautious stance.

Trump again calls coronavirus as 'China Virus'

Trump again calls coronavirus as 'China Virus'

Rediff.com25 Aug 2020

In March, he had said that China is responsible for the spread of the novel coronavirus and called the COVID-19 as the "Chinese Virus".

Is it the end of brand 'Maggi' or will Nestle strike back?

Is it the end of brand 'Maggi' or will Nestle strike back?

Rediff.com2 Jun 2015

Experts question Nestle's silence over Maggi controversy.

Sensex, Nifty at their lowest close in 2015; bluechips drag

Sensex, Nifty at their lowest close in 2015; bluechips drag

Rediff.com8 Jun 2015

Markets ended their lowest close in 2015 on fears of FII outflows as the US Fed may hike rates.

Trump declares national emergency to combat coronavirus

Trump declares national emergency to combat coronavirus

Rediff.com14 Mar 2020

The deadly virus, which has killed over 5,000 people globally, has spread to 46 of the 50 US states.

Sensex soars 500 points; Nifty at 11-month high

Sensex soars 500 points; Nifty at 11-month high

Rediff.com11 Jul 2016

Nifty50 surged 145 points to close at 8,468 after hitting an intra-day high of 8,475.

Moderna says its COVID-19 vaccine is 94.5% effective

Moderna says its COVID-19 vaccine is 94.5% effective

Rediff.com16 Nov 2020

Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.

Markets end flat amid volatile trade

Markets end flat amid volatile trade

Rediff.com17 Sep 2013

Markets ended flat on Tuesday, amid a volatile trading session, as investors exercised caution ahead of the two-day FOMC meet starting today and Reserve Bank of India's monetary policy later this week.

Auto gains, IT slips in MFs allocations

Auto gains, IT slips in MFs allocations

Rediff.com15 Jan 2017

Money managers have turned cautious about the technology space.

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Yoga, moong soup... in govt's Covid health document

Yoga, moong soup... in govt's Covid health document

Rediff.com15 Dec 2021

With the threat of COVID-19 pandemic continuing to loom over the world, the Ministry of Ayush has come out with a comprehensive document putting forth the concept of 'holistic health'.

Lupin acquires US generics firm GAVIS for $880 mn

Lupin acquires US generics firm GAVIS for $880 mn

Rediff.com24 Jul 2015

Lupin will fund the buy through $100 mn cash reserves and a bridge loan.

Ranbaxy's top executives in the US resign

Ranbaxy's top executives in the US resign

Rediff.com14 Oct 2014

US country head, key departmental heads leave; more likely to follow.

Crocin Quick gives GSK a headache

Crocin Quick gives GSK a headache

Rediff.com27 Sep 2005

Sensex, Nifty Bank end at record highs

Sensex, Nifty Bank end at record highs

Rediff.com19 Jun 2017

On BSE, 1,469 shares fell and 1,200 shares rose. A total of 190 shares were unchanged.

Suspected human hair in tablet cited in Ranbaxy ban

Suspected human hair in tablet cited in Ranbaxy ban

Rediff.com18 Sep 2013

Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.

Pharma stocks could rise another 15-20%

Pharma stocks could rise another 15-20%

Rediff.com28 Jul 2014

Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine broader markets.

Weak oil prices drag markets; Nifty ends below 7,400

Weak oil prices drag markets; Nifty ends below 7,400

Rediff.com3 Feb 2016

Financials were the top losers while oil shares also declined amid weak crude oil prices.

Rate-cut hopes drive markets higher; bluechips gain

Rate-cut hopes drive markets higher; bluechips gain

Rediff.com15 May 2015

Benchmark indices finished higher on hopes of economic reforms

When it comes to pharma, Made in Gujarat is a success story

When it comes to pharma, Made in Gujarat is a success story

Rediff.com2 Jun 2016

The percentage of non-standard quality drugs in the state has been in the range of 2-2.5% as compared to an all-India average of 5-6%

India Inc lines up as demand for rapid testing for coronavirus grows

India Inc lines up as demand for rapid testing for coronavirus grows

Rediff.com3 Apr 2020

The test used now, called PCR (or polymerace chain reaction), uses a nasal or throat swab sample and identifies the virus. These tests take at least five hours to give results. The rapid test, on the other hand, uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein.

With over 85k cases, US has most Covid cases in world

With over 85k cases, US has most Covid cases in world

Rediff.com27 Mar 2020

Trump attributed the spike in the confirmed cases of coronavirus to the large-scale testing of the deadly disease.

Plasma therapy isn't proven treatment for COVID-19: Govt

Plasma therapy isn't proven treatment for COVID-19: Govt

Rediff.com29 Apr 2020

Addressing a press briefing, health ministry Joint Secretary Lav Agarwal said currently there are no approved therapies for COVID-19 and there is not enough evidence to claim that plasma therapy can be used for treatment of the disease.

My worry is whether a child is consuming excessive lead: FSSAI CEO

My worry is whether a child is consuming excessive lead: FSSAI CEO

Rediff.com7 Aug 2015

Maggi noodles was recalled in June because some states had found presence of MSG and excessive lead content in the samples.

Markets make handsome gains on December F&O expiry

Markets make handsome gains on December F&O expiry

Rediff.com31 Dec 2015

The top gainers on the Sensex are Gail(India), HDFC, Infosys.

Pfizer says its Covid vaccine is 95% effective in final trials

Pfizer says its Covid vaccine is 95% effective in final trials

Rediff.com18 Nov 2020

Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.